Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Founder, Academy of Oncology Nurse & Patient Navigators (AONN+)
Administrative Director John Hopkins Medical Institutions Baltimore, MD
Authored Items
Oncology Nursing and Cancer Care
Brenda Nevidjon, MSN, RN, FAAN
,
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
AVBCC Webcast Series
in
COVID-19
The Importance of Patient Education: A Nurse’s Perspective
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
July 2017, Supplement - Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
in
Perspectives
Last modified: April 8, 2020